carmustine has been researched along with Vascular Diseases in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jack, CR | 1 |
| Mehta, BA | 1 |
| Boulos, RS | 1 |
| Patel, SC | 1 |
| Ausman, JI | 1 |
| Malik, GM | 1 |
1 other study available for carmustine and Vascular Diseases
| Article | Year |
|---|---|
Interventional neuroradiology: Henry Ford Hospital experience with nonembolization procedures.
Topics: Adult; Aged; Angioplasty, Balloon; Arteriovenous Fistula; Basilar Artery; Carmustine; Carotid Artery | 1986 |